Skip to main content

Quality Assessment of the Preanalytical Workflow in Liquid Biobanking: Taurine as a Serum-Specific Quality Indicator for Preanalytical Process Variations.

Schwarz N, Knutti N, Rose M, Neugebauer S, Geiger J, Jahns R, Klopp N, Illig T, Mathay C, Betsou F, Scherag A, Kiehntopf M

Publication: Biopreserv Biobank (2019)PMID: 31339743View on PubMed

Purpose

The purpose of this paper was to assess how the concentration of taurine (TAU) may differ in plasma and serum specimens after a pre-centrifugation delay, as well as to assess potential effects introduced in serum by the duration and temperature of a pre-centrifugation delay, the duration of a post-centrifugation delay, and the potential association between TAU concentration and total platelet volume.

Conclusion

Concentrations of TAU remained stable in plasma after a pre-centrifugation delay of up to 240 min at room temperature. Conversely, the concentration of TAU in serum specimens displayed a significant and progressive increase with a pre-centrifugation delay at room temperature beginning after 120 min; increases that were attenuated by storage at 4°C. A post-centrifugation delay of up to 240 min did not elicit significant changes in TAU concentration in serum specimens. The authors calculated a median TAU threshold of 160 µmol/L for serum collected from healthy individuals based on data obtained after a delay-to-centrifugation and the relationship observed with total platelet volume; a threshold that would include serum specimens that experienced a delay-to-centrifugation of up to 60 min. Results were validated using a second cohort of healthy individuals as well as patients diagnosed with a cardiologic or rheumatologic pathology.

Studies (3)

Purpose

This study investigated the potential effect of a delay-to-centrifugation on taurine (TAU) concentration in plasma and serum specimens. Blood from two different cohorts consisting of 5 and 23 healthy individuals fasting for 12 h was collected into serum tubes with clot activator and EDTA, citrate, and lithium heparin plasma tubes and subjected to a pre-centrifugation delay at room temperature of 30, 60, 120, or 240 min. Plasma and serum tubes were then centrifuged at 2500 x g for 10 min at 20°C and specimens were stored at -80°C until analysis by HPLC and LC-MS/MS. TAU concentration (µmol/L) was determined by receiver operating characteristic curves (ROC) and area under the ROC (AROC). Total platelet volume was also measured. TAU concentration was plotted against total platelet volume (MPV x platelet count x 103 per µL/100) to assess the potential association between TAU concentration and platelet aggregation.

Summary of Findings

Serum specimens that experienced a room temperature delay-to-centrifugation of 60, 120, or 240 min had Tau concentrations that were 1.3, 1.4, and 1.7-fold higher; respectively, than case-matched controls processed 30 min after collection. No delay-induced changes were observed in plasma specimens. Results were equivalent among the two specimen cohorts. A positive relationship was also observed between TAU concentration and total platelet volume, and while the linear pattern of effect was similar, progressive delays to centrifugation produced more pronounced increases in TAU concentration at higher total platelet volumes. The authors calculated a median TAU threshold of 160 µmol/L for serum collected from healthy individuals based on data obtained after a delay-to-centrifugation and the relationship observed with total platelet volume; this threshold would include serum specimens that experienced a delay-to-centrifugation of 60 min or less.

  • Biospecimens

    FluidSerum
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    PeptideHPLC
    PeptideLC-MS or LC-MS/MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    LC-MS or LC-MS/MS SpecificTargeted peptide/protein
    TAU